Generics: Global Industry Guide

Generics: Global Industry Guide

The Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the Generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).

* Includes a five-year forecast of the industry

Highlights

The global generics market grew by 3.1% in 2008 to reach a value of $191.8 billion.

In 2013, the global generics market is forecast to have a value of $292 billion, an increase of 52.2% since 2008.

Sales of ethical drugs proved the most lucrative for the global generics market in 2008, generating 80.9% of the market’s overall revenue.

Americas leads the global generics market accounting for 59.7% of the market's revenue.

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The generics market consists of all sales of generic drugs for human use at ex-manufacturer prices. The defines a generic as an officially-approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name.

This definition excludes multi-source copy products that make up much of markets such as India, Spain and Italy. Multi-source copies are drugs still under patent that are offered by manufacturers other than the patent holders.

TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION 23
1.1 What is this report about? 23
1.2 Who is the target reader? 23
1.3 How to use this report 23
1.4 Definitions 23
CHAPTER 2 GLOBAL GENERICS 24
2.1 Market Overview 24
2.2 Market Value 25
2.3 Market Segmentation I 26
2.4 Market Segmentation II 27
2.5 Five Forces Analysis 28
2.6 Market Forecasts 36
CHAPTER 3 GENERICS IN ASIA-PACIFIC 37
3.1 Market Overview 37
3.2 Market Value 38
3.3 Market Segmentation I 39
3.4 Market Segmentation II 40
3.5 Five Forces Analysis 41
3.6 Market Forecasts 49
CHAPTER 4 GENERICS IN EUROPE 50
4.1 Market Overview 50
4.2 Market Value 51
4.3 Market Segmentation I 52
4.4 Market Segmentation II 53
4.5 Five Forces Analysis 54
4.6 Market Forecasts 61
4.7 Macroeconomic Indicators 62
CHAPTER 5 GENERICS IN BELGIUM 63
5.1 Market Overview 63
5.2 Market Value 64
5.3 Market Segmentation I 65
5.4 Market Segmentation II 66
5.5 Five Forces Analysis 67
5.6 Market Forecasts 74
5.7 Macroeconomic Indicators 75
CHAPTER 6 GENERICS IN CANADA 77
6.1 Market Overview 77
6.2 Market Value 78
6.3 Market Segmentation I 79
6.4 Market Segmentation II 80
6.5 Five Forces Analysis 81
6.6 Market Forecasts 88
6.7 Macroeconomic Indicators 89
CHAPTER 7 GENERICS IN CHINA 91
7.1 Market Overview 91
7.2 Market Value 92
7.3 Market Segmentation I 93
7.4 Market Segmentation II 94
7.5 Five Forces Analysis 95
7.6 Market Forecasts 102
7.7 Macroeconomic Indicators 103
CHAPTER 8 GENERICS IN FRANCE 105
8.1 Market Overview 105
8.2 Market Value 106
8.3 Market Segmentation I 107
8.4 Market Segmentation II 108
8.5 Five Forces Analysis 109
8.6 Market Forecasts 116
8.7 Macroeconomic Indicators 117
CHAPTER 9 GENERICS IN GERMANY 119
9.1 Market Overview 119
9.2 Market Value 120
9.3 Market Segmentation I 121
9.4 Market Segmentation II 122
9.5 Five Forces Analysis 123
9.6 Market Forecasts 130
9.7 Macroeconomic Indicators 131
CHAPTER 10 GENERICS IN ITALY 133
10.1 Market Overview 133
10.2 Market Value 134
10.3 Market Segmentation I 135
10.4 Market Segmentation II 136
10.5 Five Forces Analysis 137
10.6 Market Forecasts 144
10.7 Macroeconomic Indicators 145
CHAPTER 11 GENERICS IN JAPAN 147
11.1 Market Overview 147
11.2 Market Value 148
11.3 Market Segmentation I 149
11.4 Market Segmentation II 150
11.5 Five Forces Analysis 151
11.6 Market Forecasts 158
11.7 Macroeconomic Indicators 159
CHAPTER 12 GENERICS IN THE NETHERLANDS 161
12.1 Market Overview 161
12.2 Market Value 162
12.3 Market Segmentation I 163
12.4 Market Segmentation II 164
12.5 Five Forces Analysis 165
12.6 Market Forecasts 172
12.7 Macroeconomic Indicators 173
CHAPTER 13 GENERICS IN SPAIN 175
13.1 Market Overview 175
13.2 Market Value 176
13.3 Market Segmentation I 177
13.4 Market Segmentation II 178
13.5 Five Forces Analysis 179
13.6 Market Forecasts 186
13.7 Macroeconomic Indicators 187
CHAPTER 14 GENERICS IN THE UNITED KINGDOM 189
14.1 Market Overview 189
14.2 Market Value 190
14.3 Market Segmentation I 191
14.4 Market Segmentation II 192
14.5 Five Forces Analysis 193
14.6 Market Forecasts 200
14.7 Macroeconomic Indicators 201
CHAPTER 15 GENERICS IN THE UNITED STATES 203
15.1 Market Overview 203
15.2 Market Value 204
15.3 Market Segmentation I 205
15.4 Market Segmentation II 206
15.5 Five Forces Analysis 207
15.6 Market Forecasts 215
15.7 Macroeconomic Indicators 216
CHAPTER 16 COMPANY PROFILES 217
16.1 Leading Companies 217
CHAPTER 17 APPENDIX 226
17.1 Data Research Methodology 226


LIST OF TABLES
Table 1: Global Generics Market Value: $ billion, 2004-2008 25
Table 2: Global Generics Market Segmentation I: % Share, by Value, 2008 26
Table 3: Global Generics Market Segmentation II: % Share, by Value, 2008 27
Table 4: Global Generics Market Value Forecast: $ billion, 2008-2013 36
Table 5: Asia-Pacific Generics Market Value: $ billion, 2004-2008 38
Table 6: Asia-Pacific Generics Market Segmentation I: % Share, by Value, 2008 39
Table 7: Asia-Pacific Generics Market Segmentation II: % Share, by Value, 2008 40
Table 8: Asia-Pacific Generics Market Value Forecast: $ billion, 2008-2013 49
Table 9: Europe Generics Market Value: $ billion, 2004-2008 51
Table 10: Europe Generics Market Segmentation I: % Share, by Value, 2008 52
Table 11: Europe Generics Market Segmentation II: % Share, by Value, 2008 53
Table 12: Europe Generics Market Value Forecast: $ billion, 2008-2013 61
Table 13: Europe Exchange Rate, 2004-2008 62
Table 14: Belgium Generics Market Value: $ million, 2004-2008 64
Table 15: Belgium Generics Market Segmentation I: % Share, by Value, 2008 65
Table 16: Belgium Generics Market Segmentation II: % Share, by Value, 2008 66
Table 17: Belgium Generics Market Value Forecast: $ million, 2008-2013 74
Table 18: Belgium Size of Population (million) , 2004-2008 75
Table 19: Belgium GDP (Constant 2000 Prices, $ billion), 2004-2008 75
Table 20: Belgium Inflation, 2004-2008 76
Table 21: Belgium Exchange Rate, 2004-2008 76
Table 22: Canada Generics Market Value: $ billion, 2004-2008 78
Table 23: Canada Generics Market Segmentation I: % Share, by Value, 2008 79
Table 24: Canada Generics Market Segmentation II: % Share, by Value, 2008 80
Table 25: Canada Generics Market Value Forecast: $ billion, 2008-2013 88
Table 26: Canada Size of Population (million) , 2004-2008 89
Table 27: Canada GDP (Constant 2000 Prices, $ billion), 2004-2008 89
Table 28: Canada Inflation, 2004-2008 90
Table 29: Canada Exchange Rate, 2004-2008 90
Table 30: China Generics Market Value: $ billion, 2004-2008 92
Table 31: China Generics Market Segmentation I: % Share, by Value, 2008 93
Table 32: China Generics Market Segmentation II: % Share, by Value, 2008 94
Table 33: China Generics Market Value Forecast: $ billion, 2008-2013 102
Table 34: China Size of Population (million) , 2004-2008 103
Table 35: China GDP (Constant 2000 Prices, $ billion), 2004-2008 103
Table 36: China Inflation, 2004-2008 104
Table 37: China Exchange Rate, 2004-2008 104
Table 38: France Generics Market Value: $ billion, 2004-2008 106
Table 39: France Generics Market Segmentation I: % Share, by Value, 2008 107
Table 40: France Generics Market Segmentation II: % Share, by Value, 2008 108
Table 41: France Generics Market Value Forecast: $ billion, 2008-2013 116
Table 42: France Size of Population (million) , 2004-2008 117
Table 43: France GDP (Constant 2000 Prices, $ billion), 2004-2008 117
Table 44: France Inflation, 2004-2008 118
Table 45: France Exchange Rate, 2004-2008 118
Table 46: Germany Generics Market Value: $ billion, 2004-2008 120
Table 47: Germany Generics Market Segmentation I: % Share, by Value, 2008 121
Table 48: Germany Generics Market Segmentation II: % Share, by Value, 2008 122
Table 49: Germany Generics Market Value Forecast: $ billion, 2008-2013 130
Table 50: Germany Size of Population (million) , 2004-2008 131
Table 51: Germany GDP (Constant 2000 Prices, $ billion), 2004-2008 131
Table 52: Germany Inflation, 2004-2008 132
Table 53: Germany Exchange Rate, 2004-2008 132
Table 54: Italy Generics Market Value: $ million, 2004-2008 134
Table 55: Italy Generics Market Segmentation I: % Share, by Value, 2008 135
Table 56: Italy Generics Market Segmentation II: % Share, by Value, 2008 136
Table 57: Italy Generics Market Value Forecast: $ million, 2008-2013 144
Table 58: Italy Size of Population (million) , 2004-2008 145
Table 59: Italy GDP (Constant 2000 Prices, $ billion), 2004-2008 145
Table 60: Italy Inflation, 2004-2008 146
Table 61: Italy Exchange Rate, 2004-2008 146
Table 62: Japan Generics Market Value: $ billion, 2004-2008 148
Table 63: Japan Generics Market Segmentation I: % Share, by Value, 2008 149
Table 64: Japan Generics Market Segmentation II: % Share, by Value, 2008 150
Table 65: Japan Generics Market Value Forecast: $ billion, 2008-2013 158
Table 66: Japan Size of Population (million) , 2004-2008 159
Table 67: Japan GDP (Constant 2000 Prices, $ billion), 2004-2008 159
Table 68: Japan Inflation, 2004-2008 160
Table 69: Japan Exchange Rate, 2004-2008 160
Table 70: Netherlands Generics Market Value: $ million, 2004-2008 162
Table 71: Netherlands Generics Market Segmentation I: % Share, by Value, 2008 163
Table 72: Netherlands Generics Market Segmentation II: % Share, by Value, 2008 164
Table 73: Netherlands Generics Market Value Forecast: $ million, 2008-2013 172
Table 74: Netherlands Size of Population (million) , 2004-2008 173
Table 75: Netherlands GDP (Constant 2000 Prices, $ billion), 2004-2008 173
Table 76: Netherlands Inflation, 2004-2008 174
Table 77: Netherlands Exchange Rate, 2004-2008 174
Table 78: Spain Generics Market Value: $ million, 2004-2008 176
Table 79: Spain Generics Market Segmentation I: % Share, by Value, 2008 177
Table 80: Spain Generics Market Segmentation II: % Share, by Value, 2008 178
Table 81: Spain Generics Market Value Forecast: $ million, 2008-2013 186
Table 82: Spain Size of Population (million) , 2004-2008 187
Table 83: Spain GDP (Constant 2000 Prices, $ billion), 2004-2008 187
Table 84: Spain Inflation, 2004-2008 188
Table 85: Spain Exchange Rate, 2004-2008 188
Table 86: United Kingdom Generics Market Value: $ billion, 2004-2008 190
Table 87: United Kingdom Generics Market Segmentation I: % Share, by Value, 2008 191
Table 88: United Kingdom Generics Market Segmentation II: % Share, by Value, 2008 192
Table 89: United Kingdom Generics Market Value Forecast: $ billion, 2008-2013 200
Table 90: United Kingdom Size of Population (million) , 2004-2008 201
Table 91: United Kingdom GDP (Constant 2000 Prices, $ billion), 2004-2008 201
Table 92: United Kingdom Inflation, 2004-2008 202
Table 93: United Kingdom Exchange Rate, 2004-2008 202
Table 94: United States Generics Market Value: $ billion, 2004-2008 204
Table 95: United States Generics Market Segmentation I: % Share, by Value, 2008 205
Table 96: United States Generics Market Segmentation II: % Share, by Value, 2008 206
Table 97: United States Generics Market Value Forecast: $ billion, 2008-2013 215
Table 98: United States Size of Population (million) , 2004-2008 216
Table 99: United States GDP (Constant 2000 Prices, $ billion), 2004-2008 216
Table 100: United States Inflation, 2004-2008 216
Table 101: Key Facts: Teva Pharmaceutical Industries 217
Table 102: Key Financials: Teva Pharmaceutical Industries 220
Table 103: Key Facts: Sandoz GmbH 221
Table 104: Key Facts: Mylan Laboratories Inc. 223
Table 105: Key Financials: Mylan Laboratories Inc. 225


LIST OF FIGURES
Figure 1: Global Generics Market Value: $ billion, 2004-2008 25
Figure 2: Global Generics Market Segmentation I: % Share, by Value, 2008 26
Figure 3: Global Generics Market Segmentation II: % Share, by Value, 2008 27
Figure 4: Forces Driving Competition in the Global Generics Market, 2008 28
Figure 5: Drivers of Buyer Power in the Global Generics Market, 2008 30
Figure 6: Drivers of Supplier Power in the Global Generics Market, 2008 31
Figure 7: Factors Influencing the Likelihood of New Entrants in the Global Generics Market, 2008 32
Figure 8: Factors Influencing the Threat of Substitutes in the Global Generics Market, 2008 33
Figure 9: Drivers of Degree of Rivalry in the Global Generics Market, 2008 35
Figure 10: Global Generics Market Value Forecast: $ billion, 2008-2013 36
Figure 11: Asia-Pacific Generics Market Value: $ billion, 2004-2008 38
Figure 12: Asia-Pacific Generics Market Segmentation I: % Share, by Value, 2008 39
Figure 13: Asia-Pacific Generics Market Segmentation II: % Share, by Value, 2008 40
Figure 14: Forces Driving Competition in the Generics Market in Asia-Pacific, 2008 41
Figure 15: Drivers of Buyer Power in the Generics Market in Asia-Pacific, 2008 43
Figure 16: Drivers of Supplier Power in the Generics Market in Asia-Pacific, 2008 44
Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in Asia-Pacific, 2008 45
Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in Asia-Pacific, 2008 47
Figure 19: Drivers of Degree of Rivalry in the Generics Market in Asia-Pacific, 2008 48
Figure 20: Asia-Pacific Generics Market Value Forecast: $ billion, 2008-2013 49
Figure 21: Europe Generics Market Value: $ billion, 2004-2008 51
Figure 22: Europe Generics Market Segmentation I: % Share, by Value, 2008 52
Figure 23: Europe Generics Market Segmentation II: % Share, by Value, 2008 53
Figure 24: Forces Driving Competition in the Generics Market in Europe, 2008 54
Figure 25: Drivers of Buyer Power in the Generics Market in Europe, 2008 56
Figure 26: Drivers of Supplier Power in the Generics Market in Europe, 2008 57
Figure 27: Factors Influencing the Likelihood of New Entrants in the Generics Market in Europe, 2008 58
Figure 28: Factors Influencing the Threat of Substitutes in the Generics Market in Europe, 2008 59
Figure 29: Drivers of Degree of Rivalry in the Generics Market in Europe, 2008 60
Figure 30: Europe Generics Market Value Forecast: $ billion, 2008-2013 61
Figure 31: Belgium Generics Market Value: $ million, 2004-2008 64
Figure 32: Belgium Generics Market Segmentation I: % Share, by Value, 2008 65
Figure 33: Belgium Generics Market Segmentation II: % Share, by Value, 2008 66
Figure 34: Forces Driving Competition in the Generics Market in Belgium, 2008 67
Figure 35: Drivers of Buyer Power in the Generics Market in Belgium, 2008 69
Figure 36: Drivers of Supplier Power in the Generics Market in Belgium, 2008 70
Figure 37: Factors Influencing the Likelihood of New Entrants in the Generics Market in Belgium, 2008 71
Figure 38: Factors Influencing the Threat of Substitutes in the Generics Market in Belgium, 2008 72
Figure 39: Drivers of Degree of Rivalry in the Generics Market in Belgium, 2008 73
Figure 40: Belgium Generics Market Value Forecast: $ million, 2008-2013 74
Figure 41: Canada Generics Market Value: $ billion, 2004-2008 78
Figure 42: Canada Generics Market Segmentation I: % Share, by Value, 2008 79
Figure 43: Canada Generics Market Segmentation II: % Share, by Value, 2008 80
Figure 44: Forces Driving Competition in the Generics Market in Canada, 2008 81
Figure 45: Drivers of Buyer Power in the Generics Market in Canada, 2008 83
Figure 46: Drivers of Supplier Power in the Generics Market in Canada, 2008 84
Figure 47: Factors Influencing the Likelihood of New Entrants in the Generics Market in Canada, 2008 85
Figure 48: Factors Influencing the Threat of Substitutes in the Generics Market in Canada, 2008 86
Figure 49: Drivers of Degree of Rivalry in the Generics Market in Canada, 2008 87
Figure 50: Canada Generics Market Value Forecast: $ billion, 2008-2013 88
Figure 51: China Generics Market Value: $ billion, 2004-2008 92
Figure 52: China Generics Market Segmentation I: % Share, by Value, 2008 93
Figure 53: China Generics Market Segmentation II: % Share, by Value, 2008 94
Figure 54: Forces Driving Competition in the Generics Market in China, 2008 95
Figure 55: Drivers of Buyer Power in the Generics Market in China, 2008 97
Figure 56: Drivers of Supplier Power in the Generics Market in China, 2008 98
Figure 57: Factors Influencing the Likelihood of New Entrants in the Generics Market in China, 2008 99
Figure 58: Factors Influencing the Threat of Substitutes in the Generics Market in China, 2008 100
Figure 59: Drivers of Degree of Rivalry in the Generics Market in China, 2008 101
Figure 60: China Generics Market Value Forecast: $ billion, 2008-2013 102
Figure 61: France Generics Market Value: $ billion, 2004-2008 106
Figure 62: France Generics Market Segmentation I: % Share, by Value, 2008 107
Figure 63: France Generics Market Segmentation II: % Share, by Value, 2008 108
Figure 64: Forces Driving Competition in the Generics Market in France, 2008 109
Figure 65: Drivers of Buyer Power in the Generics Market in France, 2008 111
Figure 66: Drivers of Supplier Power in the Generics Market in France, 2008 112
Figure 67: Factors Influencing the Likelihood of New Entrants in the Generics Market in France, 2008 113
Figure 68: Factors Influencing the Threat of Substitutes in the Generics Market in France 2008 114
Figure 69: Drivers of Degree of Rivalry in the Generics Market in France, 2008 115
Figure 70: France Generics Market Value Forecast: $ billion, 2008-2013 116
Figure 71: Germany Generics Market Value: $ billion, 2004-2008 120
Figure 72: Germany Generics Market Segmentation I: % Share, by Value, 2008 121
Figure 73: Germany Generics Market Segmentation II: % Share, by Value, 2008 122
Figure 74: Forces Driving Competition in the Generics Market in Germany, 2008 123
Figure 75: Drivers of Buyer Power in the Generics Market in Germany, 2008 125
Figure 76: Drivers of Supplier Power in the Generics Market in Germany, 2008 126
Figure 77: Factors Influencing the Likelihood of New Entrants in the Generics Market in Germany, 2008 127
Figure 78: Factors Influencing the Threat of Substitutes in the Generics Market in Germany, 2008 128
Figure 79: Drivers of Degree of Rivalry in the Generics Market in Germany, 2008 129
Figure 80: Germany Generics Market Value Forecast: $ billion, 2008-2013 130
Figure 81: Italy Generics Market Value: $ million, 2004-2008 134
Figure 82: Italy Generics Market Segmentation I: % Share, by Value, 2008 135
Figure 83: Italy Generics Market Segmentation II: % Share, by Value, 2008 136
Figure 84: Forces Driving Competition in the Generics Market in Italy, 2008 137
Figure 85: Drivers of Buyer Power in the Generics Market in Italy, 2008 139
Figure 86: Drivers of Supplier Power in the Generics Market in Italy, 2008 140
Figure 87: Factors Influencing the Likelihood of New Entrants in the Generics Market in Italy, 2008 141
Figure 88: Factors Influencing the Threat of Substitutes in the Generics Market in Italy, 2008 142
Figure 89: Drivers of Degree of Rivalry in the Generics Market in Italy, 2008 143
Figure 90: Italy Generics Market Value Forecast: $ million, 2008-2013 144
Figure 91: Japan Generics Market Value: $ billion, 2004-2008 148
Figure 92: Japan Generics Market Segmentation I: % Share, by Value, 2008 149
Figure 93: Japan Generics Market Segmentation II: % Share, by Value, 2008 150
Figure 94: Forces Driving Competition in the Generics Market in Japan, 2008 151
Figure 95: Drivers of Buyer Power in the Generics Market in Japan, 2008 153
Figure 96: Drivers of Supplier Power in the Generics Market in Japan, 2008 154
Figure 97: Factors Influencing the Likelihood of New Entrants in the Generics Market in Japan, 2008 155
Figure 98: Factors Influencing the Threat of Substitutes in the Generics Market in Japan, 2008 156
Figure 99: Drivers of Degree of Rivalry in the Generics Market in Japan, 2008 157
Figure 100: Japan Generics Market Value Forecast: $ billion, 2008-2013 158
Figure 101: Netherlands Generics Market Value: $ million, 2004-2008 162
Figure 102: Netherlands Generics Market Segmentation I: % Share, by Value, 2008 163
Figure 103: Netherlands Generics Market Segmentation II: % Share, by Value, 2008 164
Figure 104: Forces Driving Competition in the Generics Market in the Netherlands, 2008 165
Figure 105: Drivers of Buyer Power in the Generics Market in the Netherlands, 2008 167
Figure 106: Drivers of Supplier Power in the Generics Market in the Netherlands, 2008 168
Figure 107: Factors Influencing the Likelihood of New Entrants in the Generics Market in the Netherlands, 2008 169
Figure 108: Factors Influencing the Threat of Substitutes in the Generics Market in the Netherlands, 2008 170
Figure 109: Drivers of Degree of Rivalry in the Generics Market in the Netherlands, 2008 171
Figure 110: Netherlands Generics Market Value Forecast: $ million, 2008-2013 172
Figure 111: Spain Generics Market Value: $ million, 2004-2008 176
Figure 112: Spain Generics Market Segmentation I: % Share, by Value, 2008 177
Figure 113: Spain Generics Market Segmentation II: % Share, by Value, 2008 178
Figure 114: Forces Driving Competition in the Generics Market in Spain, 2008 179
Figure 115: Drivers of Buyer Power in the Generics Market in Spain, 2008 181
Figure 116: Drivers of Supplier Power in the Generics Market in Spain, 2008 182
Figure 117: Factors Influencing the Likelihood of New Entrants in the Generics Market in Spain, 2008 183
Figure 118: Factors Influencing the Threat of Substitutes in the Generics Market in Spain, 2008 184
Figure 119: Drivers of Degree of Rivalry in the Generics Market in Spain, 2008 185
Figure 120: Spain Generics Market Value Forecast: $ million, 2008-2013 186
Figure 121: United Kingdom Generics Market Value: $ billion, 2004-2008 190
Figure 122: United Kingdom Generics Market Segmentation I: % Share, by Value, 2008 191
Figure 123: United Kingdom Generics Market Segmentation II: % Share, by Value, 2008 192
Figure 124: Forces Driving Competition in the Generics Market in the United Kingdom, 2008 193
Figure 125: Drivers of Buyer Power in the Generics Market in the United Kingdom, 2008 195
Figure 126: Drivers of Supplier Power in the Generics Market in the United Kingdom, 2008 196
Figure 127: Factors Influencing the Likelihood of New Entrants in the Generics Market in the United Kingdom, 2008 197
Figure 128: Factors Influencing the Threat of Substitutes in the Generics Market in the United Kingdom, 2008 198
Figure 129: Drivers of Degree of Rivalry in the Generics Market in the United Kingdom, 2008 199
Figure 130: United Kingdom Generics Market Value Forecast: $ billion, 2008-2013 200
Figure 131: United States Generics Market Value: $ billion, 2004-2008 204
Figure 132: United States Generics Market Segmentation I: % Share, by Value, 2008 205
Figure 133: United States Generics Market Segmentation II: % Share, by Value, 2008 206
Figure 134: Forces Driving Competition in the Generics Market in the United States, 2008 207
Figure 135: Drivers of Buyer Power in the Generics Market in the United States, 2008 209
Figure 136: Drivers of Supplier Power in the Generics Market in the United States, 2008 210
Figure 137: Factors Influencing the Likelihood of New Entrants in the Generics Market in the United States, 2008 211
Figure 138: Factors Influencing the Threat of Substitutes in the Generics Market in the United States, 2008 212
Figure 139: Drivers of Degree of Rivalry in the Generics Market in the United States, 2008 214
Figure 140: United States Generics Market Value Forecast: $ billion, 2008-2013 215
Figure 141: Revenues & Profitability: Teva Pharmaceutical Industries 220
Figure 142: Revenues & Profitability: Mylan Laboratories Inc. 225